Invited Speakers
|
Hiromi Matsubara MD, PhD · Director, Entire Medical Departments · Director, Department of Cardiology · National Hospital Organization, Okayama Medical Center · Clinical Professor of Cardiovascular Medicine · Okayama University Graduate School of Medicine Dentistry and Pharmaceutical sciences |
|
Keiko Yamauchi-Takihara, MD, PhD · Director of Health Care Center in Osaka University · Professor of Department of Cardiovascular Medicine · Osaka University Graduate School of Medicine · Trustee of National Cerebral and Cardiovascular Center, Japan |
|
Kuo-Yang Wang, MD · Chairman, Taiwan Pulmonary Hypertension Association (TPHA) · Director, Center for Pulmonary Hypertension and Pulmonary Vascular Disease, China Medical University Hospital, Taichung, Taiwan |
|
Takeshi Ogo, MD, PhD · Department of Advanced medical research for pulmonary hypertension · Division of pulmonary circulation, Department of cardiovascular medicine National cardiovascular center, Osaka, Japan |
|
Zhi-Cheng Jing, MD · Tenured Professor of Medicine and, Director of Key Lab of Pulmonary Vascular Medicine · Thrombosis and Haemostasis Center, National Center for Cardiovascular Disease, FuWai Hospital · State Key Lab of Cardiovascular Disease, Pekin Union Medical College and Chinese Academy Medical Sciences |
|
Stephan Rosenkranz, MD · Chair, Cologne Cardiovascular Research Center (CCRC) · Head of Expert Center on Pulmonary Hypertension, the University of Cologne Head ("Principal Investigator") of working group on "Molecular Cardiology"; Research focus: Signal transduction and pathobiological relevance of receptor tyrosine kinases in cardiovascular disease |